The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Share News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 31st Mar 2014 10:41

African Minerals: Credit Suisse cuts target price from 280p to 200p maintaining a neutral rating.Anglo American: Credit Suisse reduces target price from 1900p to 1800p and retains an outperform rating.ARM Holdings: Barclays takes target price from 1125p to 1200p and reiterates an overweight recommendation.ASOS: Barclays increases target price from 6000p to 8000p, while its overweight rating remains unchanged.Berendsen: UBS raises target price from 950p to 1100p keeping a neutral rating.Cello Group: N+1 Singer lowers target price from 123p to 122p and retains a buy recommendation.Clinigen Group: Numis takes target price from 620p to 650p upgrading to buy.Daily Mail & General Trust: Westhouse Securities upgrades from neutral to add with a target price of 960p.Darty: N+1 Singer ups target price to 140p and upgrades to buy.easyJet: Numis raises target price from 1900p to 2100p upgrading to buy.Ferrexpo: Barclays shifts target price from 170p to 175p and keeps a neutral rating.Filtronic: Panmure Gordon reduces target price from 84p to 54p downgrading from buy to hold.Glencore Xstrata: Credit Suisse cuts target price from 400p to 380p and retains an outperform rating.Grainger: Jefferies ups target price from 239p to 260p and maintains a buy recommendation.ITE Group: Westhouse Securities cuts target price from 215p to 206p and maintains a neutral rating.Johnson Matthey: UBS raises target price from 3215p to 3275p and reiterates a neutral rating.London Mining: Credit Suisse cuts target price from 170p to 140p leaving its outperform rating unaltered.Majestic Wine: N+1 Singer cuts target price to 470p, while keeping its buy recommendation.Morrison (Wm): Societe Generale cuts target price from 200p to 170p and stays with its sell recommendation.Petards: Northland Capital reinitiates with a target price of 18p and a buy recommendation.Phoenix Group: canaccord Genuity cuts target price from 865p to 800p, while leaving its buy recommendation unchanged.Reckitt Benckiser: Deutsche Bank raises target price from 5100p to 6000p and retains its buy recommendation.Regenersis: Panmure Gordon places both its target price and its buy recommendation under review.Sage Group: Numis raises target price from 383p to 420p, while keeping its hold recommendation.Sainsbury: Societe Generale cuts target price from 370p to 330p reiterating its hold recommendation.Shanks Group: Investec downgrades from buy to add with a target price of 120p.Sportech: Panmure Gordon ups target price from 153p to 184p maintaining a buy recommendation.Travis Perkins: UBS moves target price from 2090p to 2100p and keeps a buy recommendation.Vedanta Resources: Credit Suisse cuts target price from 1270p to 1150p, while staying with its outperform rating.YouGov: Numis ups target price from 109p to 142p maintaining a buy recommendation.Zambeef: Panmure Gordon places both its target price (prev.: 28p) and its sell recommendation under review.
More News
12 Sep 2018 16:00

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 13 September GVC HoldingsHalf Year ResultsWM Morrison SupermarketsHalf Year Year

Read more
16 Aug 2018 16:45

Cello Health injects pharma duo to board of directors

(Sharecast News) - Healthcare advisory group Cello Health on Thursday appointed independent non-executive directors Clifford Tompsett and Jo LeCouilliard to its board of directors.

Read more
16 Aug 2018 15:00

Cello Health Appoints Two New Non-Executive Directors

LONDON (Alliance News) - Cello Health PLC said Thursday that it has appointed, with immediate effect, Clifford Tompsett and Joanna LeCouilliard as non-executive directors.Tompsett is a of a

Read more
19 Jul 2018 11:47

Cello Health Reports "Good Growth" In Half-Year Revenue And Profit

LONDON (Alliance News) - Healthcare-focused advisory firm Cello Health PLC said Thursday it had a "strong" first-half performance with "good growth" in revenue and company that

Read more
9 May 2018 12:35

Cello Health Starts 2018 Well And Expects Solid Trading To Continue

LONDON (Alliance News) - Healthcare-focused advisory firm Cello Health PLC said on Wednesday at its annual general meeting that it has had a strong start to 2018 and expects this to said that, in

Read more
19 Jan 2017 08:55

Cello Group Expects 2016 Results In line With Consensus Expectations

Read more
5 Oct 2016 15:39

DIRECTOR DEALINGS: Cello Group Executive Buys Shares

Read more
16 May 2016 08:15

Cello To Book GBP5.3 Million Total Charge After UK Tax Agreement

Read more
10 May 2016 06:51

Cello Confident On 2016 After Good Start For Health And Signal Units

Read more
3 May 2016 15:15

AGM, EGM Calendar - Week Ahead

Read more
23 Mar 2016 16:32

Cello Group Says UK Tax Authority Rejects Settlement Offer

Read more
17 Mar 2016 11:13

Cello Group Annual Profit Grows And Makes Good Start To 2016

Read more
17 Mar 2016 09:38

BROKER RATINGS SUMMARY: HSBC Starts Housebuilders With Buy Ratings

Read more
27 Jan 2016 12:15

Cello says 2015 trading in line; new year has started well

(ShareCast News) - Health and consumer strategic marketing company Cello Group said trading in the year ended 31 December 2015 was good, with revenue and profit in line with market expectations. The group said its health division maintained good like-for-like revenue growth and a competitive profit

Read more
27 Jan 2016 09:39

Cello Says 2015 Profit And Revenue In Line, US Expansion Boost Growth

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.